Accuracy and safety of technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile (Sestamibi) myocardial scintigraphy with high dose dipyridamole test in patients with effort angina pectoris: a multicenter study. Italian Group of Nuclear Cardiology

CNR Institute of Clinical Physiology, Pisa, Italy.

Clinical and physiologic evidence indicates that maximal coronary vasodilation is not achieved in a large number of patients with use of the standard dose of dipyridamole (0.56 mg/kg body weight over 4 min). The feasibility, safety and accuracy of technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile (Sestamibi) scintigraphy associated with intravenous high dose dipyridamole (0.56 mg/kg over 4 min followed 4 min later by an additional 0.28 mg/kg over 2 min) were evaluated in a multicenter study. Planar myocardial perfusion images were obtained at rest and after dipyridamole in 101 patients with effort chest pain and no prior myocardial infarction. High dose dipyridamole (62 patients) was used when typical chest pain or electrocardiographic (ECG) signs of ischemia, or both, did not occur during or after the standard dose (39 patients). With high dose dipyridamole, 34 patients had pain (18 patients) or ECG signs of ischemia (ST depression greater than or equal to 2 mm) (8 patients), or both (8 patients), whereas the other 28 patients had Sestamibi injection in the absence of symptoms or ECG changes. All patients underwent coronary angiography: 81 had significant coronary artery disease (greater than or equal to 50% reduction of lumen diameter) (affecting one vessel in 38, two vessels in 19 and three vessels in 24 patients) and 20 patients had normal coronary arteries. The overall sensitivity, specificity and predictive accuracy of Sestamibi scintigraphy were 81%, 90% and 83%, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				R. T. George, C. Silva, M. A.S. Cordeiro, A. DiPaula, D. R. Thompson, W. F. McCarthy, T. Ichihara, J. A.C. Lima, and A. C. Lardo Multidetector Computed Tomography Myocardial Perfusion Imaging During Adenosine Stress J. Am. Coll. Cardiol., July 4, 2006; 48(1): 153 - 160. [Abstract] [Full Text] [PDF]

				S. V. Williams, S. D. Fihn, and R. J. Gibbons Guidelines for the Management of Patients with Chronic Stable Angina: Diagnosis and Risk Stratification Ann Intern Med, October 2, 2001; 135(7): 530 - 547. [Abstract] [Full Text] [PDF]

				J. Taki, S. Fujino, K. Nakajima, I. Matsunari, H. Okazaki, T. Saga, H. Bunko, and N. Tonami 99mTc-Sestamibi Retention Characteristics During Pharmacologic Hyperemia in Human Myocardium: Comparison with Coronary Flow Reserve Measured by Doppler Flowire J. Nucl. Med., October 1, 2001; 42(10): 1457 - 1463. [Abstract] [Full Text] [PDF]

				G.R Ciliberto, L Ruffini, M Mangiavacchi, M Parolini, R Sara, D Massa, R De Maria, E Gronda, E Vitali, and O Parodi Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation Eur. Heart J., June 1, 2001; 22(11): 964 - 971. [Abstract] [PDF]

				K. Wei, E. Le, J.-P. Bin, M. Coggins, A. R. Jayawera, and S. Kaul Mechanism of reversible 99mTc-sestamibi perfusion defects during pharmacologically induced vasodilatation Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1896 - H1904. [Abstract] [Full Text] [PDF]

				S. C. Smart, A. Bhatia, R. Hellman, T. Stoiber, A. Krasnow, B. D. Collier, and K. B. Sagar Dobutamine-atropine stress echocardiography and dipyridamole sestamibi scintigraphy for the detection of coronary artery disease: limitations and concordance J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1265 - 1273. [Abstract] [Full Text] [PDF]

				Z.-X. He, E. Cwajg, W. Hwang, C. J. Hartley, E. Funk, L. H. Michael, and M. S. Verani Myocardial Blood Flow and Myocardial Uptake of 201Tl and 99mTc-Sestamibi During Coronary Vasodilation Induced by CGS-21680, a Selective Adenosine A2A Receptor Agonist Circulation, July 25, 2000; 102(4): 438 - 444. [Abstract] [Full Text] [PDF]

				W. G. Hundley, C. A. Hamilton, M. S. Thomas, D. M. Herrington, T. B. Salido, D. W. Kitzman, W. C. Little, and K. M. Link Utility of Fast Cine Magnetic Resonance Imaging and Display for the Detection of Myocardial Ischemia in Patients Not Well Suited for Second Harmonic Stress Echocardiography Circulation, October 19, 1999; 100(16): 1697 - 1702. [Abstract] [Full Text] [PDF]

				R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina) J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197. [Full Text] [PDF]

				B. Lagana, O. Schillaci, L. Tubani, R. Gentile, R. Danieli, R. Coviello, L. Baratta, F. Scopinaro, and B. Lagana Lupus Carditis: Evaluation with Technetium-99m MIBI Myocardial SPECT and Heart Rate Variability Angiology, February 1, 1999; 50(2): 143 - 148. [Abstract] [PDF]

				R. M. Fleming, C. H. Rose, and K. M. Feldmann Comparing a High-Dose Dipyridamole SPECT Imaging Protocol with Dobutamine and Exercise Stress Testing Protocols Angiology, July 1, 1995; 46(7): 547 - 556. [Abstract] [PDF]

				D. K. Glover, M. Ruiz, N. C. Edwards, M. Cunningham, J. P. Simanis, W. H. Smith, D. D. Watson, and G. A. Beller Comparison Between 201Tl and 99mTc Sestamibi Uptake During Adenosine-Induced Vasodilation as a Function of Coronary Stenosis Severity Circulation, February 1, 1995; 91(3): 813 - 820. [Abstract] [Full Text]

				B. L. Zaret and F. J. Wackers Nuclear Cardiology- First of Two Parts N. Engl. J. Med., September 9, 1993; 329(11): 775 - 783. [Full Text]